Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04753723 · ClinicalTrials.gov registry record · Phase 4
The Use of a Platform Wound Device for Reducing Infection
A Phase 4 study of Wounds and Injury and Burn Wound, sponsored by The Metis Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
- 4
- Study locations
NCT04753723 is a Phase 4 study of Wounds and Injury and Burn Wound that has completed, run by The Metis Foundation. The registered enrollment target is 48 participants, below the 1,399-participant average among 6 other Wounds and Injury trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT04753723, a Phase 4 study of Wounds and Injury and Burn Wound, has completed, sponsored by The Metis Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will evaluate the safety and efficacy of a novel Platform Wound Device (PWD) in its delivery of a local antibiotic, 0.1% Gentamycin cream, to prevent or treat infection in torso and extremity wounds. The hypothesis is that the PWD will be a safe and effective method to provide topical antibiotics to a torso or extremity wound, non-inferior to the current standard of care. This treatment will reduce or rapidly eradicate infection.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Gentamycin with Platform Wound Device
Study Locations (4)
Texas
- Baptist Medical Center - San Antonio
- North East Baptist Hospital - San Antonio
- Mission Trail Baptist Hospital - San Antonio
- North Central Baptist Hospital - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2022-05-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04753723
The ClinicalTrials.gov registry entry for NCT04753723 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,399-participant average among 6 other Wounds and Injury trials with a reported enrollment target (97% lower). The listed sponsor is The Metis Foundation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Wounds and Injury appearing as the primary indexed condition, and to 1 intervention - of which Gentamycin with Platform Wound Device is the first listed.
NCT04753723 reports 4 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04753723 about?
NCT04753723 is a clinical study titled "The Use of a Platform Wound Device for Reducing Infection". This study will evaluate the safety and efficacy of a novel Platform Wound Device (PWD) in its delivery of a local antibiotic, 0.1% Gentamycin cream, to prevent or treat infection in torso and extremity wounds. The hypothesis is that the PWD will be a safe and effective method to provide topical ant...
What is the current status of trial NCT04753723?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2021-02-08. Estimated completion is 2022-05-25.
What conditions does trial NCT04753723 study?
This clinical trial studies the following conditions: Wounds and Injury, Burn Wound, Infection Wound.
What interventions are being tested in trial NCT04753723?
The interventions under investigation include: Gentamycin with Platform Wound Device (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04753723?
This trial is sponsored by The Metis Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04753723 being conducted?
This trial has 4 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wounds and Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Human Upper Extremity Allotransplantation: F/U Protocol
RECRUITING
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients
ACTIVE NOT RECRUITING · Phase 3
-
Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention
ACTIVE NOT RECRUITING · NA
-
Strategy to Avoid Excessive Oxygen in Major Burn Patients
ACTIVE NOT RECRUITING · Phase 3
-
Investigation of Laser Assisted Drug Delivery of NanoDOX®
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.